Graft decentering in DSAEK: a risk factor for immune reactions? – (Eye 30, 1147 (August 2016))
Graft decentering in DSAEK: a risk factor for immune reactions? Eye 30, 1147 (August 2016). doi:10.1038/eye.2016.76 Authors: T Lapp, S Heinzelmann, W A Shanab, T Reinhard & D Boehringer
Patient satisfaction in the Peterborough community specialist optometrist in glaucoma shared-care scheme – (Eye 30, 1149 (August 2016))
Patient satisfaction in the Peterborough community specialist optometrist in glaucoma shared-care scheme Eye 30, 1149 (August 2016). doi:10.1038/eye.2016.80 Authors: H W Roberts, M Sood, S Sood, A Kotecha & S Ramirez-Florez
Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ – (Eye 30, 1150 (August 2016))
Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ Eye 30, 1150 (August 2016). doi:10.1038/eye.2016.82 Authors: D A Godefrooij, G A de Wit, M J Mangen & R P L Wisse
Response to: Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ – (Eye 30, 1152 (August 2016))
Response to: Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ Eye 30, 1152 (August 2016). doi:10.1038/eye.2016.85 Authors: A Salmon, D Chalk, K Stein & A Frost
Predictors of stereoacuity outcome in visually mature subjects with exotropia – (Eye 30, 1154 (August 2016))
Predictors of stereoacuity outcome in visually mature subjects with exotropia Eye 30, 1154 (August 2016). doi:10.1038/eye.2016.151 Authors: F Koç & N Sefi-Yurdakul